Glenn Greenberg's Trades In Q1 2015

Author's Avatar
Jun 11, 2015

Brave Warrior Advisors, LLC is an employee owned investment manager. The original Chieftain hedge fund was founded by Glenn Greenberg (Trades, Portfolio) and John Shapiro in 1984 in New York City with a capital of $40 million mostly from their families. Due to disagreements regarding management, the duo announced splitting of the $2 billion-plus fund in late 2009. Shapiro started the new Chieftain in January 2010, and Greenberg renamed his own fund Brave Warrior Advisors. The firm primarily provides its services to high net worth individuals.

The portfolio of Glenn Greenberg is composed of 15 stocks and has a total value of $3,276 million. During the 2015 Q1 he did the following trades :

He increased by 34.41% his stake in Halliburton Co (HAL) with an impact of 1.91% on his portfolio. After this add he holds 5,566,104 shares of the company that represent the 0.65% of HAL’s outstanding shares or 7.46% of his total assets.

The company is a provider of services and products to the energy industry related to the exploration, development and production of oil and natural gas. It serves national and independent oil and natural gas companies.

During the last 12 months the price of the stock declined by 31%; is now trading with a P/E(ttm) ratio of 17.80 and according to the DCF model looks overpriced by 9%.

He reduced by 29.49% his stake in Kinder Morgan, Inc (KMI) with an impact of 1.82% on his portfolio. After this sale he holds 2,960,0671 shares of the company that represent the 0.14% of KMI’s outstanding shares or 3.8% of his total assets.

The company along with its subsidiaries owns an interest in or operates approximately 80,000 miles of pipelines and 180 terminals.

During the last 12 months the price of the stock rose by 15%; is now trading with a P/E(ttm) ratio of 45.90 and according to the DCF model looks overpriced by 210%.

He reduced by 14.51% his stake in Express Scripts Holding Co (ESRX) with an impact of 1.76% on his portfolio. After this sale he holds 3,495,539 shares of the company that represent the 0.48% of ESRX’s outstanding shares or 9.26% of his total assets.

The company operates as a Pharmacy benefit management in North America. It helps health benefit providers address access and affordability concerns resulting from rising drug costs while helping to improve healthcare outcomes.

During the last 12 months the price of the stock rose by 23%; is now trading with a P/E(ttm) ratio of 31.10 and according to the DCF model looks overpriced by 26%.

He increased by 21.67% his stake in Microsoft Corp (MSFT) with an impact of 1.38% on his portfolio. After this add he holds 6,229,600 shares of the company that represent the 0.07% of MSFT’s outstanding shares or 7.73% of his total assets.

The company generates revenue by developing, manufacturing, licensing, and supporting software products and services for different types of computing devices.

During the last 12 months the price of the stock rose by 14%; is now trading with a P/E(ttm) ratio of 19.80 and according to the DCF model looks overpriced by 14%.

He reduced by 4.07% his stake in Valeant Pharmaceuticals International Inc (VRX) with an impact of 1.24% on his portfolio. After this sale he holds 5,877,016 shares of the company that represent the 1.72% of VRX’s outstanding shares or 35.64% of his total assets.

The company is a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets a range of branded, generic and branded generic pharmaceuticals, over-the-counter products (OTC) and medical devices, and aesthetics devices, which are marketed directly or indirectly in over 100 countries.

During the last 12 months the price of the stock rose by 83%; is now trading with a P/E (ttm) ratio of 85.90 and according to the DCF model looks overpriced by 426%.

He increased by 15.74% his stake in JPMorgan Chase & Co (JPM) with an impact of 1.21% on his portfolio. After this add he holds 4,817,762 shares of the company that represent the 0.13% of JPM’s outstanding shares or 8.91% of his total assets.

The company's activities are organized, for management reporting purposes, into various business segments, such as Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking and Asset Management.

During the last 12 months the price of the stock rose by 19%, is now trading with a P/E (ttm) ratio of 12.60 and, according to the DCF model, looks undervalued by 21%.

He reduced by 10.52% his stake in Cimpress NV (CMPR) with an impact of 0.78% on his portfolio. After this sale he holds 2,535,629 shares of the company that represent the 7.73% of CMPR’s outstanding shares or 6.53% of his total assets.

The company provides online customized marketing products and services. It offers business cards, brochures, holiday cards, calendars, direct mail services, promotional gifts, signage, website design and hosting services and email marketing services.

During the last 12 months the price of the stock rose by 110%, is now trading with a P/E(ttm) ratio of 29.10 and,, according to the DCF model looks overpriced by 96%.

He increased by 8.47% his stake in Charles Schwab Corp (SCHW) with an impact of 0.67% on his portfolio. After this add he holds 9,192,231 shares of the company that represent the 0.07% of SCHW’s outstanding shares or 8.54% of his total assets.

The company provides financial services to individuals and institutional clients through two segments namely Investor Services and Advisor Services.

During the last 12 months the price of the stock rose by 28%, is now trading with a P/E (ttm) ratio of 36.00 and, according to the DCF model, looks overpriced by 202%.

He reduced by 10.07% his stake in Primerica Inc (PRI) with an impact of 0.44% on his portfolio. After this sale he holds 2,108,727 shares of the company that represent the 4.11% of PRI’s outstanding shares or 3.28% of his total assets.

The company is a distributor of financial products to middle-income households in the United States and Canada. The company helps its clients to meet their needs for term life insurance.

During the last 12 months the price of the stock dropped by 1%, is now trading with a P/E(ttm) ratio of 14.10 and, according to the DCF model, looks undervalued by 6%.

He increased by 3.45% his stake in Equinix Inc (EQIX) with an impact of 0.21% on his portfolio. After this add he holds 881,835 shares of the company that represent the 1.55% of EQIX’s outstanding shares or 6.27% of his total assets.

The company offer its services to enterprises, financial services companies and content and network service providers. It connects more than companies directly to their customers and partners inside the world's networked data centers.

During the last 12 months the price of the stock rose by 29%; is now trading with a forward P/E ratio of 36.76.

He increased by 4.76% his stake in Baker Hughes Inc (BHI) with an impact of 0.03% on his portfolio. After this add he holds 378,244 shares of the company that represent the 0.09% of BHI’s outstanding shares or 0.73% of his total assets.

The company is a supplier of oilfield services, products, technology and systems to the oil and natural gas industry. It also provides industrial and other products and services to the downstream refining, and the process and pipeline industries.

During the last 12 months the price of the stock dropped by 8%, is now trading with a P/E(ttm) ratio of 36.20 and, according to the DCF model, looks overpriced by 343%.